Senior Marketing Pipeline Strategy Cardiometabolic Manager

New Jersey, USA (On-site)

$120K/yr – $223K/yrSenior Level7+ years expFull time

Posted 10 days ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Own and coordinate early commercialization efforts across cross-functional teams to align strategy, messaging, and execution from clinical development through launch.

  • Lead cross-functional collaboration and planning with marketing, market access, and medical teams.
  • Support development of early commercialization strategy, brand positioning, and go-to-market plans.

Job Description

Responsibilities

  • Cross-Functional Collaboration & Planning: Help the Sr Dir to foster early strategic alignment across cross-functional teams including marketing, market access, and medical teams and to ensure a cohesive approach to early product commercialization. Collaborate with global commercial teams and ensure input to asset planning across other key NNI stakeholders
  • Early Commercialization Strategy: Contribute to early commercialization strategy development to maximize asset value and market penetration, leveraging global products and insights, insights from clinical trials, and market research. Collaborate with marketing, market access, and medical affairs teams to develop early brand positioning, priority customer segments, messaging, and go-to-market strategies and input into evidence generation plans before the product is transitioned to the launch team
  • Market Assessment and Opportunity Analysis: Assist completion of thorough market assessments and opportunity analyses to identify target patient populations, unmet needs, and competitive positioning strategies
  • Target Product Profile (TPP) Development Support: Provide support for clinical trial strategy, regulatory development, and the development of Target Product Profiles (TPPs) to ensure alignment with commercialization goals. Gather input from clinical and regulatory teams to understand clinical data / patient outcomes, identify market opportunities, address regulatory requirements, and help to shape product development strategies
  • Regulatory Compliance: Ensure early commercialization strategies comply with regulatory guidelines and industry standards, working closely with regulatory affairs teams to address any compliance-related issues
  • Commercialization Transition: Support facilitation of the smooth transition of products from clinical development into commercialization at the time the launch planning process begins. Ensure continuity of market research and therapy area knowledge, decision processes, and early strategy from early development phases to commercialization efforts, maintaining alignment with overarching brand strategies
  • Knowledge Transfer and Pull-Through: Assist in facilitating knowledge transfer between early commercial and marketing brand/therapy area teams, ensuring key insights, learnings, and strategic considerations are effectively communicated and incorporated into commercialization plans. Work with cross-functional teams to pull through clinical insights, patient profiles, and early competitive positioning strategies into launch commercialization efforts to maximize product potential
  • Project Management and Coordination Support: Assist project management efforts to coordinate transition between clinical development and commercialization teams, ensuring milestones are met. Identify and flag potential risks or challenges during the transition process, proactively addressing issues to minimize disruptions and ensure continuity of product development efforts
  • Continuous Improvement and Optimization: Aid continuous improvement initiatives to optimize the product transition process, implementing best practices, tools, and methodologies to streamline workflows and enhance efficiency

Requirements

  • Bachelor’s degree
  • 7+ years of experience, including product marketing, product management, or market research / insights & analytics within the pharmaceutical industry
  • Demonstrated success in early commercial planning, launching, and managing products
  • Knowledge of pharmaceutical regulatory requirements and experience interacting with regulatory agencies
  • Proven knowledge of the pharmaceutical industry, including competitive market dynamics, and trends, especially within preferred
  • Strategic mindset with ability to develop and execute innovative commercial strategies aligned with NNI objectives and market opportunities
  • Strong planning and organizational skills with high attention to detail and proven track record of results and follow up
  • Ability to manage complexity, including the management of work across competing priorities
  • Strong communication and stakeholder management skills, with ability to influence senior leaders and collaborate with cross-functional teams across the organization
  • Project management skills, with the ability to lead and coordinate complex initiatives involving multiple stakeholders

Preferred

  • Master’s degree preferred

Benefits

  • Employees are also eligible to participate in Company employee benefit programs including medical, dental and vision coverage; life insurance; disability insurance; 401(k) savings plan; flexible spending accounts; employee assistance program; tuition reimbursement program; and voluntary benefits such as group legal, critical illness, identity theft protection, pet insurance and auto/home insurance. The Company also offers time off pursuant to its sick time policy, flex-able vacation policy, and parental leave policy.

Novo Nordisk

4.3 Glassdoor

We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health.Our unordinary mindset is at the heart of everything we do. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 77,000 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com.This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to remove those that are off-topic, abusive or intended to spam. Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in: https://www.novonordisk.com/contact-us/find-local-information.htmlFor other customer complaints, please contact us here: https://www.novonordisk.com/contact-us.htmlPlease keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed. Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users.Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html

Founded in 1923
Copenhagen, Capital Region of Denmark, DNK
66K employees (3,095 in marketing)
87% recommend to a friend
95% CEO approval

Traffic Signals

Monthly Visitors
503.1K
Monthly Google Ads Budget
$119
Traffic Source Mix
Search
49.5%
Direct
35.6%
Referral
9.2%
Social
4.9%
Paid
0.7%

Headcount Trend

Current headcount: ~66.4K

Marketing Team

Marketing Team Size
2,554 (4% of company)
Median Career Experience
20.5 years
Median Tenure
8.1 years
Marketing Roles Posted (Last 30 Days)
2

Funding

Total Funding
$22M
Last Raise
$22M
Post IPO Equity, 7 years ago

Funding History

  • Dec 2018
    Post IPO Equity • $22M

Recent News